Albemarle (NYSE:ALB) Stock Bought Sen. John Boozman

Senator John Boozman (Republican-Arkansas) recently bought shares of Albemarle Corporation (NYSE:ALB). In a filing disclosed on June 16th, the Senator disclosed that they had bought between $1,001 and $15,000 in Albemarle stock on May 15th.

Senator John Boozman also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of BondBloxx Bloomberg Two Year Target Duration US Treasury ETF (NYSEARCA:XTWO) on 5/27/2026.
• Purchased $1,001 – $15,000 in shares of BondBloxx Bloomberg Five Year Target Duration US Treasury ETF (NYSEARCA:XFIV) on 5/27/2026.
• Purchased $1,001 – $15,000 in shares of Goldman Sachs Access Investment Grade Corporate Bond ETF (NYSEARCA:GIGB) on 5/27/2026.
• Purchased $1,001 – $15,000 in shares of Goldman Sachs Access Treasury 0-1 Year ETF (NYSEARCA:GBIL) on 5/27/2026.
• Purchased $1,001 – $15,000 in shares of iShares Agency Bond ETF (NYSEARCA:AGZ) on 5/27/2026.
• Purchased $1,001 – $15,000 in shares of iShares MBS ETF (NASDAQ:MBB) on 5/27/2026.
• Purchased $1,001 – $15,000 in shares of iShares CMBS ETF (NYSEARCA:CMBS) on 5/27/2026.
• Purchased $1,001 – $15,000 in shares of iShares 10-20 Year Treasury Bond ETF (NYSEARCA:TLH) on 5/27/2026.
• Purchased $1,001 – $15,000 in shares of iShares 7-10 Year Treasury Bond ETF (NASDAQ:IEF) on 5/27/2026.
• Purchased $1,001 – $15,000 in shares of Janus Henderson Mortgage-Backed Securities ETF (NYSEARCA:JMBS) on 5/27/2026.

Albemarle Stock Down 4.3%

Shares of Albemarle stock traded down $6.33 during trading hours on Thursday, hitting $141.51. 866,234 shares of the company’s stock traded hands, compared to its average volume of 2,493,109. The company has a quick ratio of 1.21, a current ratio of 2.07 and a debt-to-equity ratio of 0.23. The stock has a 50 day simple moving average of $178.65 and a 200-day simple moving average of $169.24. The company has a market cap of $16.69 billion, a PE ratio of -41.59, a PEG ratio of 0.76 and a beta of 1.30. Albemarle Corporation has a twelve month low of $60.64 and a twelve month high of $221.00.

Albemarle (NYSE:ALB) last released its earnings results on Wednesday, May 6th. The specialty chemicals company reported $2.95 earnings per share for the quarter, topping the consensus estimate of $1.24 by $1.71. Albemarle had a negative net margin of 5.00% and a positive return on equity of 5.22%. The company had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.34 billion. During the same quarter in the previous year, the firm earned ($0.18) EPS. The company’s revenue was up 32.7% on a year-over-year basis. Equities research analysts anticipate that Albemarle Corporation will post 12.39 earnings per share for the current fiscal year.

Albemarle Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Shareholders of record on Friday, June 12th will be given a $0.405 dividend. This represents a $1.62 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend is Friday, June 12th. Albemarle’s dividend payout ratio is presently -47.51%.

Insider Activity

In related news, CEO J Kent Masters sold 16,393 shares of the stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $183.72, for a total value of $3,011,721.96. Following the completion of the sale, the chief executive officer directly owned 87,519 shares of the company’s stock, valued at approximately $16,078,990.68. This represents a 15.78% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.42% of the stock is owned by insiders.

Hedge Funds Weigh In On Albemarle

Hedge funds have recently modified their holdings of the company. Evexia Wealth LLC lifted its holdings in Albemarle by 2.3% in the 1st quarter. Evexia Wealth LLC now owns 2,088 shares of the specialty chemicals company’s stock valued at $387,000 after acquiring an additional 47 shares during the last quarter. Parallel Advisors LLC raised its holdings in shares of Albemarle by 2.5% in the 4th quarter. Parallel Advisors LLC now owns 2,468 shares of the specialty chemicals company’s stock worth $349,000 after purchasing an additional 60 shares in the last quarter. Eaton Financial Holdings Company LLC lifted its stake in Albemarle by 1.2% during the fourth quarter. Eaton Financial Holdings Company LLC now owns 5,769 shares of the specialty chemicals company’s stock valued at $816,000 after purchasing an additional 66 shares during the last quarter. Sigma Planning Corp boosted its holdings in Albemarle by 2.3% during the first quarter. Sigma Planning Corp now owns 2,952 shares of the specialty chemicals company’s stock worth $530,000 after buying an additional 66 shares in the last quarter. Finally, Signature Estate & Investment Advisors LLC lifted its position in shares of Albemarle by 1.9% during the 4th quarter. Signature Estate & Investment Advisors LLC now owns 3,592 shares of the specialty chemicals company’s stock valued at $508,000 after acquiring an additional 67 shares during the last quarter. 92.87% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ALB has been the topic of a number of research reports. Scotiabank increased their target price on shares of Albemarle from $200.00 to $215.00 and gave the stock an “outperform” rating in a report on Thursday, May 14th. Wall Street Zen lowered shares of Albemarle from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 13th. Truist Financial increased their price objective on shares of Albemarle from $245.00 to $260.00 and gave the stock a “buy” rating in a research note on Friday, May 8th. Berenberg Bank lifted their target price on Albemarle from $153.00 to $192.00 and gave the company a “hold” rating in a research note on Tuesday, June 2nd. Finally, Vertical Research upgraded Albemarle from a “hold” rating to a “buy” rating and set a $224.00 price target on the stock in a research report on Tuesday, May 26th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Albemarle presently has a consensus rating of “Moderate Buy” and a consensus price target of $202.54.

About Senator Boozman

John Boozman (Republican Party) is a member of the U.S. Senate from Arkansas. He assumed office on January 3, 2011. His current term ends on January 3, 2029. Boozman (Republican Party) ran for re-election to the U.S. Senate to represent Arkansas. He won in the general election on November 8, 2022. Boozman won re-election in 2016. He faced Democrat Conner Eldridge, Libertarian Frank Gilbert, and write-in candidate Jason Tate in the general election. Arkansas’ U.S. Senate race was rated as safely Republican in 2016. Boozman began his political career in the U.S. House. He won a special election in 2001 and served in that position until his election to the Senate in 2010. Prior to his political career, Boozman worked as an optometrist. As of a 2014 analysis of multiple outside rankings, Boozman is an average Republican member of Congress, meaning he will vote with the Republican Party on the majority of bills. Below is an abbreviated outline of Boozman’s academic, professional, and political career: 2011-Present: U.S. Senator from Arkansas 2001-2011: U.S. Representative from Arkansas 1977: Graduated from Southern College of Optometry

About Albemarle

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.